Safety of Retroviral Vectors: Regulatory and Technical Considerations

Concepts in Genetic Medicine

Volumn , Issue , 2007, Pages 277-288

  Cornetta, Kenneth ^a   Wilson, Carolyn A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Gamma retroviral vectors; Moloney murine leukemia virus (MoMLV); Severe combined immunodeficiency (SCID)

Indexed keywords

EID: 79952190182     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470184585.ch23     Document Type: Chapter

References (49)

1. Bassin RH, Ruscetti S, Ali I, Haapala D, Rein A (1982). Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology. 123: 139-151.
2. Bauer Jr. TR, Miller AD, Hickstein DD (1995). Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope. Blood. 86:2379-2387.
3. Bayle JY, Johnson LG, St. George JA, Boucher RC, Olsen JC (1993). High-efficiency gene transfer to primary monkey airway epithelial cells with retrovirus vectors using the gibbon ape leukemia virus receptor. Hum Gene Ther. 4:161-170.
4. Berns A (2004). Good news for gene therapy. New Engl J Med. 350:1679-1680.
5. Bodine DM, McDonagh KT, Brandt SJ, et al. (1990). Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc the Nat Acad Sci USA. 87:3738-3742.
6. Bonham L, Wolgamot G, Miller AD (1997). Molecular cloning of Mus dunni endogenous virus: an unusual retrovirus in a new murine viral interference group with a wide host range. J Virol. 71:4663-4670.
7. Bosselman RA, Hsu R-Y, Bruszewski J, Hu S, Martin F, Nicolson M (1987). Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney leukemia virus structural genes via the metallothionein promoter. Mol Cell Biol. 7:1797-1806.
8. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA (1995). High-efficiency retroviral-mediated gene transfer into human and non-human primate peripheral blood lymphocytes. Proc Nat Acad Sci, USA. 92:7739-7743.
9. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672.
10. Chen J, Reeves L, Cornetta K (2001a). Safety testing for replication-competent retrovirus (RCR) associated with gibbon ape leukemia virus pseudotyped retroviral vectors. Hum Gene Ther. 12:61-70.
11. Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K (2001b). Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research. Virology. 282:186-197.
12. Chong H, Starkey W, Vile RG (1998). A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol. 72:2663-2670.
13. Cornetta K (1992). Safety aspects of human gene therapy. Br J Haematol. 80:421-426.
14. Cornetta K, Nguyen N, Morgan RA, Muenchau DD, Hartley J, Anderson WF (1993). Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther. 4:579-588.
15. Cosset F, Takeuchi Y, Battini J, Weiss RA, Collins MKL (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol. 69:7430-7436.
16. Danos O, Mulligan RC (1988). Safe and efficient generation of recombinant retroviruses with amphotroic and ecotropic host ranges. Proc Nat Acad Sci, USA. 85:6460-6464.
17. Dave UP, Jenkins NA, Copeland NG (2004). Gene therapy insertional mutagenesis insights. Science. 303:333.
18. Donahue RE, Kessler SW, Bodine D, et al. (1992). Helper virus induction T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med. 176:1125-1135.
19. Duffy L, Koop S, Fyffe J, Cornetta K (2003). Extended S+/L-assay for detecting replication competent retroviruses (RCR) pseudotyped with the RD114 viral envelope. Preclinica. May-June:53-59.
20. Forestell SP, Dando JS, Bohnlein E, Rigg RJ (1996). Improved detection of replication-competent retrovirus. J Virol Methods. 60:171-178.
21. Garrett E, Miller AR-M, Goldman J, Apperley JF, Melo JV (2000). Characterization of recombinant events leading to the production of an ecotropic replication-competent retrovirus in a GP+ env AM12-derived producer cell line. Virology. 266:170-179.
22. Goerner M, Horn PA, Peterson L, et al. (2001). Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotyped oncoretrovirus vectors. Blood. 98:2065-2070.
23. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. New Engl J Med. 346: 1185-1193.
24. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. (2003a). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J Med. 348:255-256.
25. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. (2003b). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302: 415-419 [erratum appears in Science. 2003;302;568].
26. Kelly PF, Vandergriff J, Nathwani A, Nienhuis AW, Vanin EF (2000). Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood. 96:1206-1214.
27. Lander MR, Chattopadhyay SK (1984). A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic and mink cell focus-forming viruses. J Virol. 52:695-696.
28. Li Z, Dullman J, Schiedlmeier B, et al. (2002). Murine leukemia induced by retroviral gene marking. Science. 296:497.
29. Long Z, Li L-P, Grooms T, et al. (1998). Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells. Hum Gene Ther. 9:1165-1172.
30. Mann R, Mulligan RC, Baltimore D (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 33:153-159.
31. Markowitz D, Goff S, Bank A (1988a). Construction and use of a safe and efficient amphotropic packaging line. Virology. 167:400-406.
32. Markowitz D, Goff S, Bank A (1988b). A safe packaging line for gene transfer: seperating viral genes on two different plasmids. J Virol. 62:1120-1124.
33. Martineau D, Klump WM, McCormack JE, et al. (1997). Evaluation of PCR and ELISA assays for screening clinical trial subjects for recplication competent retrovirus. Hum Gene Ther. 8:1231-1241.
34. Miller AD (1990). Retrovirus packaging cells. Hum Gene Ther. 1:5-14.
35. Miller AD, Rosman GJ (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:980-990.
36. Miller AD, Garcia JV, Von Suhr N, Lynch CM, Wilson C, Eiden MV (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol. 65:2220-2224.
37. Miller AD, Bonham L, Alfano J, Kiem HP, Reynolds T, Wolgamot G (1996). A novel murine retrovirus identified during testing for helper virus in human gene transfer trials. J Virol. 70:1804-1809.
38. Morgan RA, Cornetta K, Anderson WF (1990). Application of polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Hum Gene Ther. 1:136-149.
39. Muenchau DD, Freeman SM, Cornetta K, Zwiebel JA, Anderson WF (1990). Analysis of retroviral packaging lines for generation of replication-competent virus. Virology 176:262-265.
40. Otto E, Jones-Trower A, Vanin EF, et al. (1994). Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther. 5:567-575.
41. Patience C, Takeuch Y, Cosset FL, Weiss RA (2001). MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. Dev Biol. 106:169-179.
42. Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N (1995). Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Gene Ther. 2:143-150.
43. Reeves L, Duffy L, Koop S, Fyffe J, Cornetta K (2002). Detection of ecotropic replication-competent retroviruses: Comparison of S+/L-and marker rescue assays. Hum Gene Ther. 13:1783-1790.
44. Rosenberg N, Joelicoer P (1997). Retroviral pathogenesis. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press: 475-586.
45. Scarpa M, Cournoyer D, Muzny DM, Moore KA, Belmont JW, Caskey CT (1991). Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology. 180:849-852.
46. von Kalle C, Kiem HP, Goehle S, et al. (1994). Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood. 84(9):2890-2897.
47. Watanabe S, Temin HM (1983). Construction of a helper cell line for avian reticuloen-dotheliosis virus cloning vectors. Mol Cell Biol. 3:2241-2249.
48. Wilson C, Reitz MS, Okayama H, Eiden MV (1989). Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J Virol. 63:2374-2378.
49. Wilson CA, Ng T, Miller AE (1997). Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors. Hum Gene Ther. 8:869-874.